Danyelza
Naxitamab · BTG International Inc.
PRESCRIPTION ONLY (USA)Danyelza ingredients
| Active ingredient | Strength |
|---|---|
| Naxitamab | 40 mg/10mL |
What Danyelza is used for
Danyelza is a specialist medicine (glycolipid disialoganglioside-directed antibody). Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- Danyelza
- Generic name
- Naxitamab
- Made by
- BTG International Inc.
- Forms
- Injection
- Given
- Intravenous
- Drug class
- Glycolipid Disialoganglioside-directed Antibody
- FDA approval
- Biologic licence (BLA) BLA761171
- On the US market since
- 2026
Official information
- Danyelza prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Naxitamab)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Danyelza?
Danyelza (Naxitamab) is a specialist medicine made by BTG International Inc., approved by the US FDA.
What are the ingredients of Danyelza?
Danyelza contains Naxitamab (40 mg/10mL).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA